Drug class
Second-line antitubercular antibiotic; D-alanine analogue
Mechanism of action
Inhibits alanine racemase and D-alanine:D-alanine ligase, enzymes required for bacterial peptidoglycan synthesis, impairing mycobacterial cell-wall formation.
General use cases
- Treatment of active tuberculosis caused by susceptible Mycobacterium tuberculosis as part of a multidrug regimen when first-line or preferred agents cannot be used or drug resistance is present; specialist monitoring is required due to neuropsychiatric toxicity
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
